HIF1A and cancer: The aberrant activation of PI3K-AKT-mTOR signaling induces the overexpression of HIF-1 in cancer [70], and the dual PI3K/mTOR inhibitor, NVP-BEZ235, suppresses hypoxia-induced HIF-1 expression and enhances apoptosis of cancer cells under hypoxic stress [71].